report-image

Trastuzumab Emtansine Market Analysis by Application (Breast Cancer), by Type (60mg, 100mg, 150mg, 160mg, Others), and by distribution channel (Hospitals, Clinics, speciality care centers Others) and by Region: Global Forecast, 2024 - 2034

  • PUBLISHED ON
  • 2024-04-24
  • NO OF PAGES
  • 231
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Trastuzumab Emtansine market is predicted to develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it is projected to reach USD xx Million, based on an average growth pattern. The market is estimated to reach a value of USD xx Million in 2024.


SOURCE: We Market Research

Kadcyla, also known as trastuzumab emtansine, is a targeted treatment for breast cancer that is HER2-positive. It combines two drugs: emtansine, a chemotherapeutic medication, and trastuzumab, which inhibits HER2 protein signaling. Emtansine damages the microtubule network of cancer cells, causing them to die, while trastuzumab binds to the HER2 receptors on those cells. By concentrating on cancer cells, this combination reduces harm to healthy tissue. When other therapies have failed and breast cancer has progressed or returned, it is frequently utilized. Transtuzumab emtansine can improve treatment efficacy and minimize adverse effects by delivering chemotherapy straight to cancer cells, giving patients with advanced HER2-positive breast cancer hope.

The growing prevalence of HER2-positive breast cancer, improvements in cancer treatment that favor targeted therapies, and the drug's shown ability to improve patient outcomes are some of the factors driving the market for trastuzumab emtansine (T-DM1). Other important factors include raising awareness, improving access to healthcare, and continuing research and development. Together, these elements propel the demand for trastuzumab emtansine, a targeted and efficient therapy option that gives patients with HER2-positive breast cancer hope and shapes the market's growth trajectory.

Market Scope

Report Attributes

Description

Market Size in 2024

USD xx Million

Market Forecast in 2034

USD xx Million

CAGR % 2024-2034

xx%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2034

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

by Application, by Type, by distribution channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Trastuzumab Emtansine Industry: Dynamics & Restrains


 Market opportunity:


 

We Market Research: Trastuzumab Emtansine Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.


Trastuzumab Emtansine Segmentation

Market- By Application Analysis

By Application, the Trastuzumab Emtansine Market is Categories into Breast Cancer. The Breast Cancer segment accounts for the largest share.

For HER2-positive breast cancer, trastuzumab emtansine is a beneficial treatment choice because it provides targeted therapy that targets cancer cells directly while causing the least amount of harm to healthy cells. Its application has enhanced the prognosis and quality of life for HER2-positive breast cancer patients, underscoring the need of tailored strategies in cancer care.

The following segments are part of an in-depth analysis of the global Trastuzumab Emtansine market:

Market Segments

 

By Type

·         60mg

·         100mg

·         150mg

·         160mg

·         Others

By distribution channel

·         Hospitals

·         Clinics

·         speciality care centers

·         Others

 

Trastuzumab Emtansine Industry: Regional Analysis

North America Market Forecast

North America dominate the Trastuzumab Emtansine Market with the highest revenue generating market with share of more than 46%. The Trastuzumab Emtansine market in North America thrives due to the Advanced healthcare infrastructure, coupled with a high prevalence of breast cancer and substantial research investments, position the region as a leader in Trastuzumab Emtansine adoption and development.


Europe Market Statistics

Europe is the second largest region in Trastuzumab Emtansine market due to the demand for Trastuzumab Emtansine is driven in European countries by a combination of strong healthcare systems, advantageous reimbursement regulations, and increasing awareness efforts.

 Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Trastuzumab Emtansine market during the forecast period. In the Asia Pacific region, Trastuzumab Emtansine has a major market opportunity in the area due to rapidly increasing healthcare investments and a burgeoning patient population seeking sophisticated cancer medicines.

Key Market Players

The Trastuzumab Emtansine Market is dominated by a few large companies, such as

·         Amgen

·         Pfizer

·         Genentech

·         Accord Healthcare

·         Nippon Kayaku

·         Chugai Pharmaceutical

·         Daiichi Sankyo

·         Samsung Bioepis

·         Mylan(Viatris)

·         Celltrion

·         Other

1.      Global Trastuzumab Emtansine Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Trastuzumab Emtansine Market Scope and Market Estimation

1.2.1. Global Trastuzumab Emtansine Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Trastuzumab Emtansine Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Trastuzumab Emtansine Market

1.3.2. Technology of Global Trastuzumab Emtansine Market

1.3.3. Distribution channel  of Global Trastuzumab Emtansine Market

1.3.4. Region of Global Trastuzumab Emtansine Market

2.      Executive Summary

2.1.    Global Trastuzumab Emtansine Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Trastuzumab Emtansine Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Trastuzumab Emtansine Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Trastuzumab Emtansine Market Estimates & Forecast Trend Analysis, by TYPE

4.1.    Global Trastuzumab Emtansine Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034

4.1.1. 60mg

4.1.2. 100mg

4.1.3. 150mg

4.1.4. 160mg

4.1.5. Others

5.      Global Trastuzumab Emtansine Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Trastuzumab Emtansine Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Breast Cancer

6.      Global Trastuzumab Emtansine Market Estimates & Forecast Trend Analysis, by Distribution channel

6.1.    Global Trastuzumab Emtansine Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution channel , 2019 to 2034

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. speciality care centers

6.1.4. Others

7.      Global Trastuzumab Emtansine Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Trastuzumab Emtansine Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis

8.1.    North America Trastuzumab Emtansine Market Assessments & Key Findings

8.1.1. North America Trastuzumab Emtansine Market Introduction

8.1.2. North America Trastuzumab Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

8.1.2.1.   By TYPE

8.1.2.2.   By Application

8.1.2.3.   By Distribution channel

8.1.2.4.   By Country

8.1.2.4.1.     The U.S.

8.1.2.4.2.     Canada

8.1.2.4.3.     Mexico

9.      Europe Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis

9.1.    Europe Trastuzumab Emtansine Market Assessments & Key Findings

9.1.1. Europe Trastuzumab Emtansine Market Introduction

9.1.2. Europe Trastuzumab Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By TYPE

9.1.2.2.   By Application

9.1.2.3.   By Distribution channel

9.1.2.4.        By Country

9.1.2.4.1.     Germany

9.1.2.4.2.     U.K.

9.1.2.4.3.     France

9.1.2.4.4.     Italy

9.1.2.4.5.     Spain

9.1.2.4.6.     Russia

9.1.2.4.7.     Rest of Europe

10.  Asia Pacific Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Trastuzumab Emtansine Market Introduction

10.1.2.   Asia Pacific Trastuzumab Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By TYPE

10.1.2.2.    By Application

10.1.2.3.    By Distribution channel

10.1.2.4.    By Country

10.1.2.4.1. China

10.1.2.4.2. Japan

10.1.2.4.3. India

10.1.2.4.4. Australia

10.1.2.4.5. South Korea

10.1.2.4.6. ASEAN

10.1.2.4.7. Rest of Asia Pacific

11.  Middle East & Africa Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Trastuzumab Emtansine Market Introduction

11.1.2.   Middle East & Africa Trastuzumab Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By TYPE

11.1.2.2.    By Application

11.1.2.3.    By Distribution channel

11.1.2.4.    By Country

11.1.2.4.1. U.A.E.

11.1.2.4.2. Saudi Arabia

11.1.2.4.3. Egypt

11.1.2.4.4. South Africa

11.1.2.4.5. Rest of Middle East & Africa

12.  South America Trastuzumab Emtansine Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Trastuzumab Emtansine Market Introduction

12.1.2.   South America Trastuzumab Emtansine Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By TYPE

12.1.2.2.    By Application

12.1.2.3.    By Distribution channel

12.1.2.4.    By Country

12.1.2.4.1. Brazil

12.1.2.4.2. Argentina

12.1.2.4.3. Colombia

12.1.2.4.4. Rest of South America

13.  Competition Landscape

13.1.  Global Trastuzumab Emtansine Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Trastuzumab Emtansine Market Competition White Space Analysis, By Distribution channel

13.3.  Global Trastuzumab Emtansine Market Competition Heat Map Analysis, By Distribution channel

13.4.  Global Trastuzumab Emtansine Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Amgen.

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Pfizer

14.3.      Genentech

14.4.      Accord Healthcare

14.5.      Nippon Kayaku

14.6.      Chugai Pharmaceutical

14.7.      Daiichi Sankyo

14.8.      Samsung Bioepis

14.9.      Mylan(Viatris)

14.10.  Celltrion

14.11.  Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Trastuzumab Emtansine Market in 2024?

Trastuzumab Emtansine Market was valued at USD xx Million in 2024.

What is the growth rate for the Trastuzumab Emtansine Market?

Trastuzumab Emtansine Market size will increase at approximate CAGR of xx% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Trastuzumab Emtansine Market Are Amgen, Pfizer, Genentech, Accord Healthcare, Nippon Kayaku, Chugai Pharmaceutical, Daiichi Sankyo, Samsung Bioepis, Mylan(Viatris), Celltrion and Other.

Which region dominates the Trastuzumab Emtansine Market?

North America dominates the market with an active share of 46%.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI